Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - 06 Sep 2024 Form 4 Insider Report for NATURES SUNSHINE PRODUCTS INC (NATR)

Role
10%+ Owner
Signature
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., By: /s/ WU Yifang/Chairman
Issuer symbol
NATR
Transactions as of
06 Sep 2024
Net transactions value
-$145,189
Form type
4
Filing time
15 Oct 2024, 08:48:41 UTC
Previous filing
24 Jan 2022
Next filing
17 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NATR Common Stock Other $0 +2,968 +4% $0.000000 77,362 06 Sep 2024 by Fosun Industrial Co., Limited F1, F2
transaction NATR Common Stock Sale $18,942 -1,399 -1.8% $13.54 75,963 01 Oct 2024 by Fosun Industrial Co., Limited F2
transaction NATR Common Stock Sale $23,634 -1,800 -2.4% $13.13 74,163 08 Oct 2024 by Fosun Industrial Co., Limited F2
transaction NATR Common Stock Sale $24,262 -1,816 -2.4% $13.36 72,347 09 Oct 2024 by Fosun Industrial Co., Limited F2
transaction NATR Common Stock Sale $40,170 -3,000 -4.1% $13.39 69,347 10 Oct 2024 by Fosun Industrial Co., Limited F2
transaction NATR Common Stock Sale $21,125 -1,580 -2.3% $13.37 67,767 11 Oct 2024 by Fosun Industrial Co., Limited F2
transaction NATR Common Stock Sale $17,056 -1,300 -1.9% $13.12 66,467 14 Oct 2024 by Fosun Industrial Co., Limited F2
holding NATR Common Stock 2,854,607 06 Sep 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent shares that were issued to Fosun Industrial Co., Limited upon the delivery of certain vested restricted stock units that were initially granted to a former director of the Issuer (the "Former Director"), as agreed between the Former Director and the Reporting Person.
F2 Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person.